XML 51 R28.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Compensation Expense (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense

Stock-based compensation expense included in the Company’s consolidated statements of operations and comprehensive loss was as follows (in thousands):

 

 

 

Year Ended
December 31,

 

 

 

2022

 

 

2021

 

Research and development

 

$

850

 

 

$

508

 

General and administrative

 

 

4,597

 

 

 

2,262

 

Total

 

$

5,447

 

 

$

2,770

 

Schedule of Unrecognized Stock-Based Compensation

The following table summarizes the Company’s unrecognized stock-based compensation as of December 31, 2022:

 

 

Year Ended
December 31,

 

 

 

Unrecognized Expense
(in thousands)

 

 

Period of Recognition
(years)

 

Restricted stock units

 

$

105

 

 

 

3.2

 

Stock options

 

 

9,247

 

 

 

2.2

 

Total

 

$

9,352

 

 

 

 

Schedule of Fair Value of Stock Option Estimated on Date of Grant Using Black-Scholes Option-Pricing Model or Monte Carlo Simulation in Case of Options Granted to Executive Officers

The fair value of each stock option granted to employees, directors and non-employees was estimated on the date of grant using the Black-Scholes option-pricing model, or a Monte Carlo simulation in the case of the options granted to executive officers, with the following weighted-average assumptions:

 

 

Year Ended
December 31,

 

 

 

2022

 

 

2021

 

Risk-free interest rate

 

 

2.7

%

 

 

0.7

%

Expected dividend yield

 

 

%

 

 

%

Expected term (in years)

 

 

6.0

 

 

 

6.0

 

Expected volatility

 

 

81.3

%

 

 

85.0

%

 

Summary of Stock Option Activity Under Plans

A summary of the stock option activity under the Plans for the year ended December 31, 2022 was as follows:

 

 

 

Shares

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Life
(in years)

 

 

Aggregate
Intrinsic
Value
(in thousands)

 

Outstanding December 31, 2021

 

 

1,662,861

 

 

$

10.34

 

 

 

7.6

 

 

$

918

 

Granted

 

 

2,828,474

 

 

 

5.19

 

 

 

 

 

 

 

Exercised

 

 

(2,718

)

 

 

2.76

 

 

 

 

 

 

 

Cancelled

 

 

(177,284

)

 

 

7.83

 

 

 

 

 

 

 

Outstanding at December 31, 2022

 

 

4,311,333

 

 

$

7.07

 

 

 

8.2

 

 

$

378

 

Exercisable at December 31, 2022

 

 

1,350,357

 

 

$

9.73

 

 

 

6.2

 

 

$

328

 

Vested and expected to vest at December 31, 2022

 

 

4,311,333

 

 

$

7.07

 

 

 

8.2

 

 

$

378